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ABSTRACT
Breath analysis has potential to become a new medical diagnostic modality. In this
thesis, a method for the analysis of human expired breath was developed using gas
chromatography-mass spectroscopy. It was subsequently adopted for gas
chromatography-differential mobility spectroscopy, a modality not previously applied to
this problem. Tedlar bags and solid-phase microextraction were used for breath
sampling and concentration prior to analysis. Four fiber coatings were evaluated with
respect to selectivity and sensitivity; extraction time, gas chromatography temperature
programming, and sample storage stability were explored for optimization. The method
entails extraction and preconcentration with a polydimethylsiloxane-divinylbenzene
coated fiber for 30 min at 37°C, and extraction profiles for several compounds
demonstrate competitive adsorption. 120 compounds were identified in breath with
response variability between 23 - 117% about mean values. Feasibility of differential
mobility spectroscopy for breath analysis was established, and this method will be the
basis for future investigations on the diagnostic potential of breath analysis.
Technical Supervisor: Dr. Cristina E Davis
Title: Principal Member of the Technical Staff; Group Leader, Bioengineering
Thesis Advisor: Dr. Julie E Greenberg
Title: Principal Research Scientist, Research Laboratory of Electronics
3
[THIS PAGE INTENTIONALLY LEFT BLANK]
4
ACKNOWLEDGEMENTS
10 August 2005
I would like to thank my advisors, Dr. Cristina Davis and Dr. Julie Greenberg. Their
support and mentorship were greatly appreciated throughout my graduate experience. It
has been an honor and privilege to complete my thesis under their direction.
I would also like to recognize all of my colleagues in the Bioengineering group at Draper
Laboratory for countless hours of assistance and guidance throughout this process.
Special thanks are due to Marianna Shnayderman, Melissa Krebs, Maria Holmboe, and
Jose Trevejo for giving so generously of their time to ensure successful completion of
my thesis.
Finally, I am deeply indebted to my family and friends. It was with your support that I was
able to make it through this journey. I love you and know I will always have your love and
encouragement in anything I do.
This thesis was prepared at The Charles Stark Draper Laboratory, Inc. under
Department of the Army, Cooperative Agreement DAMD17-02-2-0006. The content of
this paper does not necessarily reflect the position or the policy of the government, and
no official endorsement should be inferred.
Publication of this thesis does not constitute approval by Draper of the sponsoring
agency of the findings of conclusions contained therein. It is published for the exchange
and stimulation of ideas.
William Merrick
William Merrick
5
[THIS PAGE INTENTIONALLY LEFT BLANK]
6
TABLE OF CONTENTS
1 Introduction .................................. ............................ 13
1.1 Overview of Research .............................................................. 13
1.2 Breath Analysis Background ......................................... 15
1.3 Gas Chromatography- Mass Spectroscopy . ........................... 20
1.4 Differential Mobility Spectroscopy (DMS) ................................... 22
1.5 Data Analysis Techniques . .............................................. 25
1.6 Summary of Research ......................................... 26
2 Materials and Methods ......... ......... ......... .......................... 28
2.1 Breath Sampling and Collection ................................................ 30
2.2 Method Development Experiments ............................................ 36
2.2.1 Selection of SPME Coating . ................................ 36
2.2.2 SPME Fiber Extraction ....................................................... 37
2.2.3 Gas Chromatography-Mass Spectrometry Settings .............. 38
2.2.4 Breath Sample Storage .................................................... 39
2.3 Breath Characterization Experiments ......................................... 39
2.3.1 Single Individual Variability ................................................ 39
2.3.2 Inter-individual Variability .................................................. 41
2.3.3 GC-DMS Methodology .................................................... 42
3 Results .................................................................. 43
3.1 Preliminary Breath Experiments ................. ........................... 43
3.1.1 Identification of breath VOCs by GC-MS ............................... 46
3.1.2 Sampling Bag Reusability ................................................... 50
3.1.3 Identification of Background . ............................. 51
3.2 Method Development .................................................... 54
3.2.1 Selection of SPME Coating . ................................ 54
3.2.2 SPME Extraction Conditions ................................................ 56
3.2.3 GC-MS Settings . .............................................. ....... 58
3.2.4 Sample Storage Time ........................................................ 60
3.3 Breath Characterization ........................................................... 63
3.3.1 Single Individual Variability using GC-MS ............................. 63
3.3.2 Inter-individual Variability .................................................. 67
4 Discussion .................................................... 75
4.1 Preliminary Breath Experiments ................................................ 75
4.1.1 Breath Collection Method ................................................... 75
4.1.2 Identification of breath VOCs by GC-MS ............................... 76
4.1.3 Breath Collection Materials ................................................. 77
4.1.4 Sampling Bag Reusability ................................................... 78
4.1.5 Identification of Background ................. .......................... 79
4.2 Method Development ...................................................... 80
4.2.1 SPME coating selection ...................................................... 80
4.2.2 Extraction Conditions ........................................................ 82
4.2.3 GC-MS Settings: resolution of pentane and isoprene ............. 83
4.2.4 Sample Storage ................. ......................................... 85
4.3 Breath Characterization ........................................................... 86
5 Conclusion ................................................................... 88
7
6 Future Directions ................... ............................................... 90
6.1 Removal of Background Contamination . .......................... 90
6.2 Field Deployable Device ........................................................... 91
References ......................................................................................... 92
8
LIST OF FIGURES
Figure 1: Biochemical pathway of isoprene generation: metabolism of mevalonate [3]. 17
Figure 2: Free radical-mediated lipid peroxidation: possible reactions and reaction
products [3] ................................................................... 18
Figure 3: Mass spectrum of Limonene ................................................................... 21
Figure 4: Total Ion Chromatogram (TIC) from Gas Chromatography-Mass Spectroscopy
(G C-M S) ................................................................... 21
Figure 5: Example of Differential Mobility Spectra ........................................................ 23
Figure 6: Total Ion Abundance (TIA) from Gas Chromatography-Differential Mobility
Spectroscopy (GC-DMS) .................................................................. ........ 24
Figure 7: Ion motion between DMS filter electrodes showing complete passage of
compensated ions (left). MEMS device for DMS developed by Sionex Corporation [38].
........................................................................................................ .............................. 2 4
Figure 8: Breath sampling apparatus .................................................................. 31
Figure 9: Schematic of a normal capnogram and typical modes of sampling [50] ......... 32
Figure 10: Schematic of solid phase microextraction assembly [52] ............................. 33
Figure 11: Typical chromatogram of breath .................................................................. 35
Figure 12: Representative chromatograms for ambient air (top), breath collection
apparatus (middle), and breath sample (bottom) -- peaks identified in Tables 3, 4, and 5
respectively .................................................................... 44
Figure 13: Representative chromatogram of breath ......................................................... 46
Figure 14: Overlayed chromatograms of breath sample (red), new bag (black), and
cleaned bag (blue). Labeled chemical peaks are: 1) DL-Limonene, 2) Eucalyptol, 3) 1,4-
Cyclohexadiene, 1-methyl-4-(l 1-methylethyl)-, 4) Benzene, 1-ethyl- 2,4-dimethyl-, 5)
Tridecane, 6) Benzofuran, 4,5,6,7-tetrahydro-3,6-dimethyl- ........................................ 51
Figure 15: Relative extraction efficiency of SPME coatings to breath VOCs ................. 55
Figure 16: Representative extraction profiles for three classes observed. Values are
given as the average ................................................................... 57
Figure 17: GC temperature profiles and the resulting total ion chromatograms (TICs).
Adjustments to the oven temperature programs result in improved compound resolution.
........................................................................ ..................... ....................................... 59
Figure 18: Storage stability of breath VOCs. Results are plotted as the average + the
standard deviation ................................................ ................... 62
Figure 19: Plot of PCA scores for breath from a single individual, ambient air, and
collection apparatus background ................................................................... 66
Figure 20: Plot of PCA scores for breath from a single individual, breath from multiple
subjects, ambient air, and collection apparatus background .......................................... 68
Figure 21: Typical chromatograms of breath from signal individual (top) and typical
breath from one of the multiple individuals (bottom) ..................................................... 69
Figure 22: Representative SPME-GC-DMS spectra from 2 subjects highlighting the
similarities and differences between acquired spectra. Subject 705 (top) and subject 711
9
(bottom). Colors represent signal intensity at the corresponding time and compensation
voltage, and scaling is the identical for each plot ........................................................... 71
Figure 23: Total Ion Abundance signals from SPME-GC-DMS analysis of breath from
tw o subjects ................................................................................................................. 72
Figure 24: Plot of PCA scores for breath from multiple individuals ............................... 74
Figure 25: Total ion abundance of breath sample from subject e701 ............................. 74
Figure 26: Reduction of phenol chromatographic peak from bag cleaning protocol.
Phenol peak in new bag (black). Phenol peak in cleaned bag (blue) ............................. 79
Figure 27: Coelution of pentane and isoprene in total ion chromatogram (TIC) ............. 84
10
LIST OF TABLES
Table 1: Summary of experiments ................................................................... 30
Table 2: SPME adsorption and sample analysis conditions . ............................. 34
Table 3: Compound identifications from ambient air chromatogram, Figure 12 (top) .... 45
Table 4: Compound identifications for breath apparatus chromatogram, Figure 12
(m iddle) ................................................................... 45
Table 5: Compound identifications for breath sample chromatogram, Figure 12 (bottom)
.................................................................................................................................. 45
Table 6: Identified Breath VOCs .................................................................. 48
Table 7: Identified VOCs in breath sample background ......... ........................... 53
Table 8: Most frequently extracted breath VOCs (n = 12 samples) ............................... 54
Table 9: Frequency of target breath VOCs in single individual (n = 10 samples) .......... 63
Table 10: Target breath VOC variability in single individual (n = 10 samples) ................ 64
Table 11: Distance calculations for breath, air and background signals ........................ 65
Table 12: Distance scores for single and multiple subject studies ................................. 68
Table 13: Euclidean distance measurements of breath TIAs ......................................... 73
Table 14: Manhattan distance measurements of breath TIAs ........................................ 73
Table 15: Correlation coefficients for breath TIAs .......................................................... 73
11
[THIS PAGE INTENTIONALLY LEFT BLANK]
12
1 INTRODUCTION
1.1 Overview of Research
Medical diagnostics are an important and growing field in healthcare. While physicians
diagnose disease based on symptoms, it is not always possible to determine the
underlying cause or genetic and complicating factors that may govern the best course of
treatment for a particular person. Thus, for many diseases, patients receive the same
treatment regardless of the specific parameters that make their case unique. As we
address this issue and develop a more personalized medical approach, there will be an
increased demand on diagnostic tools to guide the direction of treatment. Additionally,
diagnostics will be expected to provide more specific answers in a more timely manner.
In areas such as cardiovascular disease, cancer, and kidney disease, early detection
and quick response have been proven to significantly improve the outcome for patients
who might otherwise develop fatal conditions if treatment is prevented or delayed. It is
evident that rapid, sensitive diagnostics will play a critical role in delivering state-of-the
art medical care in the future.
A new diagnostic modality that has tremendous potential is exhaled breath analysis.
With false positives by screening tools and increased testing frequency with more
specialized medical areas, the potential cost effectiveness and diagnostic capability of
breath analysis can no longer be overlooked. Dozens of breath compounds show
promise as markers for disease diagnosis and management. While some researchers
have elaborated the diagnostic potential of such markers, there has been only modest
technical or clinical development to date [1, 2].
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The majority of breath analysis research has used Gas Chromatography (GC) and Mass
Spectrometry (MS). The techniques employed have been limited by variability in ambient
gas measurements and water saturated samples [3]. Effective breath analysis has
previously been difficult due to the presence of only trace volatile compounds. Early
methods for concentration can not be easily scaled for large studies or practical
application [3]. Furthermore, past techniques have overlooked potentially relevant
information in breath by focusing on only specific compounds. This goal of this project is
to develop a method for breath analysis using novel technologies to address the above
limitations. This new system will combine Solid Phase Microextraction (SPME) for
sample concentration to address the detection and scalability difficulties; Differential
Mobility Spectrometry (DMS), which can perform highly sensitive detection, is cost-
effective, and has been miniaturized making it clinically applicable; and a data analysis
technique based on cutting edge bioinformatics, which will permit analysis of the entire
breath profile.
Investigators have demonstrated that specific breath compounds like pentane and
isoprene are markers for reperfusion injury and can be elevated in ischemic and
inflammatory heart disease [4-7]. This project will form the basis for production of a
simple breath analysis device capable of diagnosis of acute cardiac distress patients in a
clinical setting and that can be administered by minimally-trained personnel. The
research presented here represents the initial phase of this project and is focused on the
development and optimization of a dynamic breath sampling method. For practical
reasons, method development was achieved using a gas chromatography-mass
spectroscopy (GC-MS) system and subsequently implemented with the novel gas
chromatography-differential mobility spectroscopy (GC-DMS) system to investigate
14
feasibility. Both systems were utilized to perform preliminary analytical work to study the
normal variations in human breath profiles.
1.2 Breath Analysis Background
Breath analysis has garnered a great deal of interest in recent medical science because
it offers a noninvasive window into normal metabolic pathways and has the potential to
illustrate how these pathways are altered in disease [8-13]. Physicians have known for
centuries that some diseases can be diagnosed simply by characteristic odors of
patients' breath. For example, a sweet, fruity breath odor (acetone) is characteristic of
poorly controlled diabetes mellitus, a fishy smell (dimethyl sulfide) accompanies
advanced liver disease, and odors of urea, a main component in urine, are very common
with patients suffering from kidney failure [1].
As early as 1927, Bogen [14] demonstrated the feasibility of using measurements of
breath alcohol content to monitor blood alcohol levels. However, it required almost three
decades to develop a device for practical use [15, 16]. Although subsequent support has
been provided for the alcohol breath test, there was originally disagreements between
scientists, governments, and law enforcement stemming from performance variability of
the device and a lack of evidence for the underlying physiological mechanisms [17]. Two
basic problems have hindered the advancement of breath diagnostics: lack of
physiological understanding and inadequate analytical technology. Advancements in
both areas should now allow the field of breath analysis to make substantial strides.
Breath exhalate is largely composed of nitrogen, oxygen, carbon dioxide, water, and
inert gases. While these compounds have proved useful in diagnosis and monitoring of
many disease conditions [18-20], it is the remaining fraction of human breath that
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represents the most valuable part for diagnostic purposes [3]. This remaining fraction is
made up of numerous volatile organic compounds (VOCs), each present in nanomolar
(ppb to ppt) concentrations in the breath [3]. In contrast to highly abundant breath
chemicals like nitrous oxide, volatile organic compounds mainly originate from the blood
and can therefore provide insights into different biochemical processes in healthy and
diseased individuals. VOCs derive from metabolic pathways and partition from the blood
via the alveolar membrane into the alveolar air. The kinetics of VOCs can be
approximated according to substance solubilities, implying that the concentrations
measured in breath are related to concentrations in blood [21]. Breath analysis can be
used diagnostically because aberrations in the concentrations of certain compounds
have been associated with various diseases or altered metabolism [22].
The age of modern breath analysis began in 1971 when Pauling et al. discovered that
normal human breath contained low, but measurable, concentrations of several hundred
different VOCs [23]. The average human breath sample contains more than 200
different volatile organic compounds and there have been more than 3000 different
VOCs observed in breath [24]. Most of these trace compounds are of an exogenous
origin, but it is the measurement of endogenous markers that are most important for
diagnostic purposes. While there exists a great deal of variation in the type and quantity
of VOCs, only a few are consistently observed across multiple subjects [24]. Many of the
most commonly occurring VOCs are derived from well understood metabolic pathways,
and in disease, these VOCs have been shown to be elevated as much as ten fold. It is
important to note that some chemicals may exist at levels below the detection capability
of GC-MS, and a more sensitive detector could provide increased opportunities to
recognize disease biomarkers. Moreover, we may discover that what defines a disease
16
is more than a simple chemical concentration threshold. Potentially, it could be relative
ratios of a complex panel of chemicals that are definitive for disease detection in breath.
Some of the most well documented compounds are described here to illustrate the type
of knowledge we now have about the origins and composition of breath. Isoprene (2-
methylbutadiene-1, 3), a potential marker in acute cardiac distress, is frequently found in
human breath. It is thought to be derived from the mevalonic acid pathway of
cholesterol synthesis [25], logically following from the fact that cholesterol is often
elevated in patients with cardiovascular disorders (Figure 1).
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Figure 1: Biochemical pathway of isoprene generation: metabolism of mevalonate [3].
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Acetone, an abundant VOC in human breath, is produced in the liver from the
decarboxylation of acetoacetate, an intermediary in the breakdown of excess Acetyl-
CoA. Excess Acetyl-CoA results from gylcolysis in response to glucose metabolism in
diabetes [26]. Alkanes, like pentane and ethane, have been shown to arise from the
oxidative degradation of polyunsaturated fatty acids [27]. Oxygen free radicals acting on
omega-3 fatty acids such as 9,12,15-linolenic acid produces ethane, whereas pentane is
the product of peroxidation of n-6 polyunsaturated acids such as 9,12,15-linolenic and
arachidonic acid (Figure 2)[28] .
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Figure 2: Free radical-mediated lipid peroxidation: possible reactions and reaction products [3].
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Breath compounds are present in concentrations in the nM to pM range [29]. This can
also be expressed as the number of molecules in dilute air, so concentrations are found
at parts-per-billion (ppb) and parts-per-trillion (ppt) levels. To improve detection
sensitivity and precision for these compounds, preconcentration may be necessary
before the sample can be analyzed with new or standard detectors, such as gas
chromatography-mass spectroscopy (GC-MS). Many techniques including chemical,
adsorptive binding, sorbent traps, and cryofocussation have been developed for
preconcentration of exhaled breath [30-32]. However, sample preparations using these
techniques are tedious, time-consuming, and impractical for in-hospital breath analysis.
Additionally, because of the high content of water and carbon dioxide in human breath, a
pre-concentrating method that excludes these substances may also aid analysis.
Solid Phase Micro-Extraction (SPME), developed by Pawliszyn, et al. [33], has gained
popularity in chemical analysis because it is fast, inexpensive, and a relatively efficient
and effective method for sampling volatile organic compounds [28, 34]. SPME has been
applied widely to the quantitative determination of specific VOCs in human breath such
as ethanol, acetone and isoprene. The types of compounds concentrated by SPME
depend on the specific phase material chosen. There are a number of SPME phases
available commercially and many more can be customized for individual purposes.
Polydimethylsiloxane (PDMS) is a standard liquid phase fiber with affinity to polar
compounds. For volatile extractions in human breath, mixed phase fibers have been
shown to be the best performing [28]. A blend with PDMS and divinylbenzene (DVB) and
one with DVB and a proprietary polyethyleneglycol called Carbowax© are examined in
this thesis.
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1.3 Gas Chromatography- Mass Spectroscopy
Gas Chromatography-Mass Spectroscopy (GC-MS) is one of the most widely used and
powerful tools for analytical chemistry and breath analysis. Although imprecision with
GC-MS instrumentation makes it a complex system to work with, it is a proven
technology for volatile chemical identification. Standardization and refinements have
been made over the last few decades that have resulted in more reproducible analysis.
GC-MS represents a device that can separate chemical mixtures into individual
components and then detect mass of those components. Sample flows through the
chromatographic column where the sample is separated according to the chemical
properties of the column. The various sample components emerge from the column into
a chamber where components are ionized through electron impact. A collimated beam of
electrons impacts the sample resulting in ionization and fragmentation of the molecule.
In quadrupole mass spectroscopy, ion masses travel through a scanning electric field,
which separates the positively charged particles by mass. After separation, mass
fragments enter a detector which amplifies the signal and catalogs the charge and mass
of the particle in a quantity called the mass-to-charge ratio (m/z). At each instance of
time, mass spectra from all the detected masses are recorded (Figure 3). Collected data
consists of chromatographic retention times, signal intensity, and mass-to-charge ratio
measurements. Signal representation is usually in the form of total ion chromatograms
(TICs) where the abundances of all ions at a particular time have been summed (Figure
4).
20
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Figure 3: Mass spectrum of Limonene
a,0
coV
.0
-0
retention time (min)
Figure 4: Total on Chromatogram (TIC) from Gas Chromatography-Mass Spectroscopy (GC-MS)
GC-MS can be used for both qualitative and quantitative sample detection. Qualitative
identification of compounds is based on mass spectral patterns since each compound
has a unique fragmentation pattern. This type of analysis looks at intensities of particular
masses as a function of time, and with specialized algorithms can match the unknown
spectra to one in a library of several thousand known mass spectra. Component
retention time (timing information based primarily on properties of the compound and
chromatographic column) can be used to locate known compounds in the TIC and
21
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enable quantification. Quantification is based on the peak area from mass
chromatograms, or in some cases, by using selected ion monitoring.
1.4 Differential Mobility Spectroscopy (DMS)
Differential Mobility Spectroscopy (DMS) can be used for chemical and biological
detection by measuring the differential mobility of ions in the sample mixture [35-42].
Analyte sample particles are ionized and filtered according to their mobility in high-
amplitude radiofrequency electric fields. Ion mobility is a property dependent on the ion's
charge, mass, and volume, as well as the applied electric field and gaseous
environment. Sample classification with differential mobility spectroscopy makes use of
the nonlinear relationship between ion mobility and field strength, where variable electric
fields are applied to the sample to produce separation [43].
After combining with a carrier gas, a gas sample enters the sensor where it is ionized by
a radioactive or ultraviolet source. In the DMS, ions are carried by a stream of nitrogen
gas into a filter region between two charged plates. The plates have a constant
radiofrequency (RF) electric field applied to them allowing for enhanced separation over
ion mobility spectroscopy (IMS), which makes use of a constant DC voltage electric field.
In DMS, the periodicity of the RF fields causes ions to have variable mobility. As a result,
ions travel in an oscillatory fashion with a bias towards the upper or lower plate [38]
(Figure 7). An additional DC compensation voltage is applied between the plates which
can correct for the bias in the ion's path. The mobility of the ion is relative to the applied
DC compensation voltage. Therefore, only compensated ions are able to traverse the
entire length of the filter chamber and collide with a Faraday detector. Uncompensated
ions fail to reach the detector and are instead scattered according to their bias towards
either filter electrode, neutralized, and carried out of the system via carrier gas. By
22
sweeping through a range of compensation voltages over a short duration, DMS can
simultaneously detect the diversity of ion species present in a sample. Constructing an
interface with gas chromatography is simple. Similar to a mass spectrometer, the ion
information provided by the DMS is enhanced by the additional dimension of information
provided by the gas chromatogram [44].
Figures 5 and 6 provide examples of signal DMS signal representation. Figure 5 shows
spectra with time on the x-axis, compensation voltage on the y-axis, and detected signal
amplitude represented by color intensities. The representation in Figure 6 is called "Total
Ion Abundance" and is similar to TIC. Here, the abundances of all compensation
voltages are summed at each instant in time.
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23
40
35
i 30
9 25 
204
0 1 2 3 4 5 6 7 8
time (min)
Figure 6: Total Ion Abundance (TIA) from Gas Chromatography-Differential Mobility Spectroscopy (GC-DMS)
Draper Laboratory has developed a sensitive, inexpensive differential mobility
spectrometer for use in chemical and biological detection [38, 45]. The technology was
licensed and further developed by Sionex Corp. (Waltham, Mass.). This sensor has
superior sensitivity and detection resolution down to the parts-per-trillion range [37]. As
a result of miniaturization, this sensor is able to be used in practical applications where
mobile or inexpensive detection is sought (Figure 7).
Figure 7: Ion motion between DMS filter electrodes showing complete passage of compensated ions (left).
MEMS device for DMS developed by Sionex Corporation [38].
A DMS sensor coupled with a pyrolyzer for sample introduction has been used to
successfully detect and identify bacteria spores as well as distinguish between related
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bacteria and bacteria of different species [42, 45]. DMS has also been used with
headspace sampling and gas chromatography for the detection of volatile organic
compound fingerprints above bacterial headspace [41]. This research represents the
first attempt to couple Gas Chromatography and Differential Mobility Spectroscopy (GC-
DMS) with Solid Phase Microextraction for breath sample introduction.
1.5 Data Analysis Techniques
The ultimate goal of this research is to develop a methodology to analyze breath using
Differential Mobility Spectroscopy. Unlike Gas Chromatography-Mass Spectroscopy, a
library of compounds and their resulting spectra has not been developed for DMS
detectors given that it is a relatively new technology. Furthermore, the spectra produced
with this technology are based on nonlinear principles. So, although there may be well
validated spectral patterns for compounds A and B, mixtures of these two compounds
are not always expected to produce a signal that is simply the superposition of their
independent signals. For a library-based analytical approach to be used, a library of all
compounds and all combinations of compounds would have to be developed; this is
impractical due to resource constraints. However, for data analysis of DMS spectra, our
group has utilized chemometric techniques and pattern recognition approaches,
specifically principal component analysis and genetic algorithm classification [41, 46].
For novel clinical applications, genetic algorithm-based pattern recognition has shown
promise as a tool for DMS data analysis. In this work, we use a commercially available
version of this algorithm, known as ProteomeQuest (Correlogic Systems, Bethesda,
MD).
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This algorithm is particularly powerful because while other research focuses on single
compounds, ProteomeQuest® determines biomarkers that account for the complex
breath signatures that may be crucial in disease detection. ProteomeQuest has been
effectively used for pathogen detection and the classification of bacteria [41]. This
pattern recognition technique identifies invariant biomarker features in the signal that are
less susceptible to normal biological variability and background noise. The method
development approach described in this paper will focus on optimizing signals for pattern
recognition. Efforts will be focused on feature resolution and noise reduction, which have
been shown to improve analysis performance.
1.6 Summary of Research
There were two purposes of the research carried out in this thesis. The first was method
development for the both GC-MS and GC-DMS systems. The second goal was to
perform preliminary analysis of the resulting breath signals from each system.
Since the combination of gas chromatography and differential mobility spectrometry has
not been used for the analysis of breath, a GC-MS system was used in parallel for
development and optimization of GC-DMS method parameters. GC-MS is well suited for
comparison as previous studies have established methods for breath analysis. While not
uniformly accepted, these methods provide a basis with which to compare our novel
techniques. GC-MS also provides standard analytical tools and techniques to monitor
the resulting breath signals which can provide quantitative guidance for method
optimization.
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Initially, we wanted to use this method development as an opportunity to identify the
variety of compounds in breath and determine which components of the signal are
derived from breath and which result from background. The next group of experiments
focused on the application of solid phase microextraction to breath. Although SPME is a
very powerful extraction technique, the choice of polymer coating and extraction
conditions can significantly impact the ability to collect quality breath samples.
Therefore, experiments were developed to answer the following questions: what type of
SPME coating should be used, how long should the fiber be exposed to breath, and at
what temperature should extraction take place? The separation of compounds in the
breath sample is the responsibility of the gas chromatographic column. The temperature
and the rate of change in temperature impact the performance of this step. The
temperature profile of the oven housing the column was optimized for maximum signal
resolution and minimum noise. The final experiment of method development aimed to
determine the stability of breath samples stored for different durations. This was
important as sample storage will be a necessary part of future applications where breath
will be collected in the field and analyzed in the laboratory.
The second type of experiments focused on characterization of normal breath. We
examined the normal variability in the composition of breath from a single individual as
well as the variability between multiple subjects. We performed quantitative analysis to
determine numerical similarity between samples using standard analytical metrics. This
work was carried out on both the GC-MS and GC-DMS and represented the first
application of an optimized breath analysis method for the GC-DMS system.
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2 MATERIALS AND METHODS
As discussed previously, there are two purposes of the experiments conducted in this
study: method development for breath collection and analysis and signal
characterization. The method development experiments were set up to explore and
optimize system parameters to provide the most robust and reproducible breath signal
possible. Methods are described here for sample collection and analysis with SPME-GC-
MS and SPME-GC-DMS systems. Emphasis is placed on exploring parameters that
improve breath signal resolution and signal-to-noise ratios. Signal resolution can simply
be thought of as how well individual breath compounds are separated from one another
in the spectra. Breath is such a complex sample that it can be difficult to get rid of
overlapping component signals in both of our evaluated spectral techniques.
As a starting point, method parameters for breath analysis were derived from literature
[28, 34, 47, 48]. Other researchers have demonstrated success using SPME for breath
analysis. However, there is no clear consensus on most appropriate SPME coating for
this application. One of the probable reasons for this is that the majority of studies
applying SPME to breath analysis have evaluated the performance of coatings with
respect to a particular VOC or category of compounds. Therefore, we first sought to
determine the fiber that yielded highest sensitivity and selectivity for the greatest number
of breath compounds. Optimization of extraction conditions followed as extraction
parameters should be determined experimentally when new combinations of polymer
coating and sample are investigated. Extraction time was analyzed to determine the
adsorption duration that would provide highest sensitivity to breath VOCs.
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Gas chromatography determines separation characteristics of compounds in the
detected signal. Therefore, GC temperature programs were developed and evaluated for
signal resolution and noise levels. The process was performed iteratively and attempts
were made to improve both performance measures with modification to temperature
profile parameters. Finally, the effects of storage on sample stability were investigated to
determine reasonable limitations on the acceptable time between sample collection and
analysis.
Prior to starting a full scale clinical trial, it is difficult to evaluate whether the breath
analysis approach described in this thesis will be valuable for disease diagnosis. Subject
sampling in this study only looks at healthy individuals - completely missing cohorts that
promise to have biomarkers for disease detection. Our goal in this limited study is to
apply breath analysis methods to a novel detection system and characterize breath
signal variability in normal populations. This provides us with a baseline evaluation of
breath signals and allows us to move forward and plan a clinical trial to identify
biomarkers in diseased patients. Table 1 outlines all of the experiments conducted as a
part of this thesis. It provides information regarding the variables examined under each
experiment and the number of samples analyzed.
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Table 1: Summary of experiments
number sample SPME additional notes
Method development
baseline breath & bag cleaning protocol
3 ambient air PDMS/DVB
3 unused bag PDMS/DVB
3 breath PDMS/DVB
3 cleaned bag PDMS/DVB
SPME coating selection
3 breath CAR/PDMS
3 breath CW/DVB
3 breath PDMS/DVB
3 breath DVB/CAR/PDMS
GC-MS settings
5 breath PDMS/DVB oven temperature profile varied
extraction time
18 breath PDMS/DVB extraction times = {1, 10,20, 30, 40, 120} min
storage stability
18 breath PDMS/DVB storage times = {0.5, 6, 12, 24, 48, 72} hrs
Chracterization of normal breath
single subject
10 breath PDMS/DVB
multiple subjects
7 breath PDMS/DVB
2.1 Breath Sampling and Collection
2.5 L Tedlar® gas sampling bags (Welch Fluorocarbon, Dover, NH) were chosen for
breath sample collection and storage. Tedlar, a polyvinyl fluoride film, is relatively non-
reactive, durable, and less diffusive than other films (e.g. Teflon®) making it well suited
for breath sampling applications [34]. Prior to first use, new sample bags were flushed
with pure nitrogen for a minimum of 10 minutes. Breath from subjects was collected via
a disposable, polyethylene mouthpiece (Allegiance Healthcare Corp., McGaw Park, IL).
A special Tedlar lay-flat-tube was fitted to bags. The tube is open when the mouthpiece
is inserted but seals and prevents sample escape when the mouthpiece is removed.
Two Teflon coated polypropylene septa were added for easy sample extraction (Figure
8).
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Figure 8: Breath sampling apparatus
In breath analysis, it is alveolar air that is most physiologically informative. Alveolar air is
defined as the volume that equilibrates with gas concentrations in the blood. However,
the technique for achieving alveolar air is not standard across the field although the
method of collection can have an appreciable influence on the results of breath testing
[3]. An exhalation is commonly divided into an initial (- 150 ml) volume of dead space
and the remainder is thought to be alveolar air. Two basic collection techniques are
found in the literature, mixed expiratory sampling and alveolar sampling, which was used
in this research [3]. Alveolar sampling requires elimination of dead space gas before
sample collection. By sampling with this method concentrations of endogenous VOCs
are two to three times higher than those in mixed expiratory air as the samples are not
diluted with dead space gas. Furthermore, alveolar breath samples have less
contamination [31, 49]. Figure 9 shows the three phases of exhalation. The goal of
alveolar sampling is to collect exhalate only in phase l.
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Figure 9: Schematic of a normal capnogram and typical modes of sampling [50]
In order to standardize the breath samples as much as possible, subjects were
instructed to breath normally for at least five breaths. On the following breath they were
asked to hold their breath for 5 sec and exhale to the end of their normal tidal volume.
The technique of breath holding has been shown to improve the quality of alveolar
sampling [51]. A breath sample was then collected by forced exhalation of the remaining
lung volume into the sampling apparatus as long as it was comfortable. This has been
determined to be best technique for non-invasive alveolar breath sampling [51]. Subjects
were instructed to repeat these steps until the bag is approximately 80% filled.
Samples were stored at room temperature and analyzed within 30 min from collection,
unless otherwise noted. Collected samples were incubated at 37°C (preheating) for 5
min before concentration with Solid-Phase Microextraction (SPME). SPME assemblies
consist of a coated fiber and a manual holder (Supelco, Bellefonte, PA) (Figure 10). With
the sample maintained at 37°C, the SPME fiber assembly is exposed to the sample for
30 min. The length of exposure is called the extraction time, and it was one of the
parameters optimized as part of method development.
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Figure 10: Schematic of solid phase microextraction assembly [52]
Prior to first use, SPME fibers were conditioned in the GC inlet following manufacturer
instructions. Before each analysis run they were conditioned at 250°C for 10 min.
Optimized extraction parameters were determined to be 30 min at 40°C. Validation of
these parameters is discussed in further detail in Sections 3.2 and 3.3. The SPME fiber
containing target VOCs was inserted into the GC inlet and thermally desorbed for 5 min
at 250°C in carrier gas with flow rate of 2.0 ml/min. During SPME fiber desorption, the
chromatographic column was held at 50°C. Desorbed volatiles were carried by helium
gas to the column opening mounted at the base of the inlet where they partitioned into
the liquid phase of the column film. Following the initial 5 min, the inlet purge was
opened, the oven temperature program began, and the gas flow rate increased forcing
the remaining VOCs onto the column. The analysis parameters, optimized as part of
method development, are summarized in Table 2. GC-MS analysis was performed using
an Agilent 5973N mass selective detector (Palo Alto, CA). Breath compounds were
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identified and quantitated from resulting spectra using ChemStation® software (Agilent
Technologies, Palo Alto, CA) and spectral database library from the US National Institute
for Standards and Technology (NIST). Additional compound verification was provided
using the Automated Mass Spectral Deconvolution and Identification System (AMDIS)
also available through NIST.
Table 2: SPME adsorption and sample analysis conditions
Fiber 65 pm PDMS/DVB
Extraction 30 min at 37°C
Desorption 5 min at 250°C
GC conditions
Column
Oven
Carrier gas
Injection port
MS conditions
Mass range
Transfer line
Quadrapole
Scans/sec
Multiplier
DB-WAXetr 30 m x 0.25 mm, 0.25 pm
50°C initial temperature
500C to 100°C at 25°C/min
to 1500C at 10°C/min (5 min hold)
to 210°C at 10°C/min (5 min hold)
2 ml/min (constant flow)
Splitless, 0.75 mm liner, 250°C
34 to 350 (m/z)
250°C
150°C
4.5
2000 eV
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Figure 11: Typical chromatogram of breath
Compounds separated and analyzed by GC-MS produce peaks in the resulting total ion
chromatogram (TIC) (Figure 11). A standard way of quantifying the amount of compound
detected is to integrate the area under the curve, also referred to as area response (AR),
of the most abundant ion in that peak. This measurement is related to concentration.
Corrected area response (ARc) refers to the area response of the MS for a particular
compound relative to the area response for phenol. This normalization was needed to
adjust for instrument fluctuations.
ARC = AR VOC in breath
ARphenol
Many of the compounds found in breath are actually exogenous contaminants from the
environment. Some of these exogenous compounds are also produced locally in the
body at levels above or below the concentrations found in the environment. Blanks
caused by sampling apparatus and ambient air were observed for comparison. A single
SPME fiber was exposed for approximately 30 min to laboratory air, the same in which
breath samples were collected. Concentrations of breath compounds in ambient air were
compared to quantities found in breath. Sampling apparatus blanks were obtained by
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filling collection bags with nitrogen gas and were analyzed with the same conditions as
breath samples (Table 2). Sampling system blanks were used to evaluate the bag
cleaning protocol and to identify sample contaminations arising from the sampling
apparatus. VOCs were defined as breath compounds if they were found in the breath at
significantly higher concentrations than in the background signal. However, a large
group of compounds were found in breath at significantly lower concentrations than in
the background. Kinetics analysis reveals that with these compounds the rate of
clearance, by hepatic and/or renal pathways for example, is greater than the rate of
introduction to the body from the environment. The concept of alveolar gradient was
developed to distinguish between the two classes of breath chemicals. Although only
compounds with positive alveolar gradients are produced endogenously, both positive
and negative compounds can provide important physiological information [24]. Using
AR, the alveolar gradient of each breath VOC was determined according to:
(AR voc in breath / ARphenol) - (AR voc in air / ARphenol)
2.2 Method Development Experiments
2.2.1 Selection of SPME Coating
Solid-phase Microextraction (SPME) is a solvent-free concentration method for the
extraction of VOCs from breath. Thin polymeric films which coat a fused-silica core, give
the SPME fiber selectivity for certain types of chemicals. Analytes partition into the
coating based on their physiochemical properties and sampling conditions. Choosing a
proper SPME fiber coating is crucial to the effectiveness of sample analysis. Some
useful and specific factors should be taken into consideration, such as polarity,
molecular weight, sample matrix, concentration range, and sampling temperature.
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Nonpolar coatings, e.g. polydimethylsiloxane (PDMS), are best used with low polarity
hydrocarbons. CarboxenTM (CAR) and divynlbenzene (DVB) fibers work well for
moderate to high concentration samples, and absorptive fibers are better for low
concentration samples. Since breath compounds are expected in nanomolar
concentrations, the following 4 fibers were chosen and compared:
85 pIm StableFlexT M Carboxen T M /Polydimethylsiloxane (CAR/PDMS)
65 pm Carbowax®/Divinylbenzene (CW/DVB)
65 pm Polydimethylsiloxane/Divinylbenzene (PDMS/DVB)
50 /30 pm StableFlexTM Divinylbenzene/Carboxen/PDMS (DVB/CAR/PDMS)
A list of target breath chemicals was developed to simplify the task of quantification.
Target chemicals were selected on the basis of frequency in breath samples. The area
responses for target breath chemicals were monitored. Comparison and selection of
fibers was based on extraction ability measured by both the number of compounds
extracted and the quantitated area responses for each target analyte in the sample.
PDMS/DVB, which is well suited for volatiles, amines, and nitroaromatic compounds,
performed best and was used for all subsequent experiments. See section 3.2 for further
details.
2.2.2 SPME Fiber Extraction
An important step in developing a SPME method for chemical analysis is determining
the appropriate time needed for the analytes to reach equilibrium. Equilibrium is defined
as the time above which additional fiber exposure to the analyte produces only minimal
increase in concentration. It is determined by the analyte concentrations, the properties
of the polymer coating, and sampling conditions. Adsorptive equilibrium is usually
attained in 2 to 30 min. The extraction time profiles were established by plotting detector
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response against extraction time (1, 10, 20, 30, 40, 120 min) for simultaneously collected
breath samples.
2.2.3 Gas Chromatography-Mass Spectrometry Settings
Breath compounds were separated by gas chromatography and quantitated in a mass
spectrometer (HP6890 and mass selective detector 5973, Hewlett-Packard, Palo Alto,
CA). This split/splitless injector was operated at 2500C with a purge flow of 47.9 ml/min
and 24:1 split ratio. Compounds were thermally desorbed in splitless mode for 5 min and
afterwards the splitter was opened and the fiber removed. Injector port pressure was
16.75 PSI with carrier gas (helium) 52.7 ml/min. For separation, a DB-WAXetr capillary
column, 30m length x 0.25mm i.d x 0.25pm film thickness, was used with 2.0ml/min
column flow. Column temperatures were programmed as follows: 500 C for 5 min, 25°
C/min to 100 ° C, 10° C/min to 1500 C, 5 min hold, 10° C/min to 210 ° C, 5 min hold. MSD
parameters were: ion mass/charge ration, 34 - 350 m/z; quadrupole temperature,
150°C; electron ionization temperature 230°C; interface temperature 250°C; electron
multiplier voltage 1490 eV; scan resolution, 4.2 scans/s. See Table 2 for a summary of
analysis conditions.
The best results for GC-MS pattern recognition are achieved when biomarker features
are well resolved. It is believed that in this application features will correlate to
compound peaks in the TIC. Therefore, the goal in GC temperature optimization was to
achieve the greatest sensitivity and compound resolution in the shortest time possible.
GC temperature parameters are often determined by trial and error. We used a standard
approach that begins with a constant ramp rate of 100 C/min. Initial temperature
adjustments, isothermal holds, slower ramping, and faster rate ramps were explored in
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the development of the GC temperature profile. Additionally, noise levels in each
resulting signal were tracked as another indication of performance.
2.2.4 Breath Sample Storage
For patient sampling in future clinical trials, it may not always be possible to analyze
samples immediately after collection. Samples may need to be stored for up to 72 hours
before analysis. Losses can occur due to adsorption or diffusion through bag walls. The
effect of sample storage time (0.5, 6, 12, 24, 48, 72 hours) on the concentration of
breath compounds in Tedlar bags was investigated. The quantities of target VOCs as
well as signal-to-noise measurements were monitored. Since exhaled breath
composition can vary from collection to collection, breath samples were simultaneously
taken from the same individual and stored and analyzed according to the same
conditions (n = 6). Three repetitions were performed for each storage time investigated.
2.3 Breath Characterization Experiments
2.3.1 Single Individual Variability
It has been established that there can be variability in the composition and quantity of
chemicals in breath for the same individual sampled at different times. Disease
biomarkers are valuable in diagnosis only if they surpass thresholds of normal variability.
In order to study the degree of variability in breath samples of a single individual, we
examined changes in the frequency and quantity of target compounds in breath.
Samples from the same individual were taken on 10 non-consecutive days at different
times of the day and without control for dietary, exercise, or other parameters. First-order
statistics were established for target analytes over the 10 samples.
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In order to attain a quantitative measure of the degree of variability, we utilized principal
component analysis (PCA), a commonly applied multivariate pattern recognition
approach in chemical analysis [53]. As powerful as PCA is, it is often used an
exploratory tool to visualize general relationships between data. Score plots of the first
two principal components can be applied as a form of cluster analysis, where
investigators try to determine if samples fall into well defined groups.
The first step in PCA is to determine the similarity between sample vectors. Data is
processed to create similarity matrices, where a numerical score is calculated to indicate
the similarity between each pair of samples. Because cluster analysis is not applicable to
the small sample sizes collected in this study, we used the standard scoring metrics from
PCA to assign a numerical description to the variability of breath samples in a single
individual. The scoring metrics used were correlation coefficient, Euclidean distance, and
Manhattan distance. Correlation coefficient is a similarity measure. Values are between
O and 1 (-1 and 1 in some applications). The closer the score is to 1 the more correlated
the samples are. Euclidean distance, the standard distance metrics used in PCA, is a
dissimilarity measure. The computed values are not limited (always > 0), but higher
Euclidian scores correspond to increasingly dissimilar samples. The Manhattan distance
is very similar to the Euclidean distance; it is a dissimilarity score and by definition is
always greater than the Euclidean distance.
Euclideandistance: D, =- (xk - x )2
Manhattan distance: D = X - |
j=l
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The distance metrics were applied to raw GC-MS total ion chromatograms (TIC), so
each point was considered a unique feature. The distance or correlation to the average
TIC was calculated for each observation. The mean distance was then reported as a
measurement of the spread or variability between the sample observations.
2.3.2 Inter-individual Variability
Unrelated individuals were solicited to volunteer breath samples according to the
collection protocol described above (n = 7 people). Collections were taken in the same
laboratory environment to minimize variation differences in ambient air quality. While
time of last meal, smoking habits, and medical conditions can greatly affect the VOC
content in breath and the quality of samples for variability analysis, this study did not
control for these parameters because practical applications will also not contain these
controls. These factors, however, were recorded. The goal of this experiment is to
identify normal breath variability across subjects irrespective of these factors. Results
are meant to provide meaningful information about the data expected from our future
clinical trials where parameters such as those listed above will not be controlled.
Both GC-MS and GC-DMS systems were used to study inter-individual variability. This
also represented the first opportunity to evaluate the robustness of GC-DMS for breath
analysis. Two identical PDMS/DVB coated SPME fibers were simultaneously exposed to
each sample for extraction. Based on equilibrium calculations, simultaneous extraction
leads to reduction in extracted compound concentrations. However, the relative
abundances of compounds are maintained in both SPME fibers, theoretically preserving
the ratio of complex biomarkers embedded in the spectral signals. This is in contrast to
serial extractions where the second fiber may extract drastically different relative
abundances as a consequence of the complexities in adsorption kinetics. Euclidean
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similarity scores were computed for GC-MS and GC-DMS spectra and compared to
similarity scores developed to describe variations in single individual sampling. Principal
component analysis (PCA) was performed to provide visual representation of single
individual and inter-individual variability.
2.3.3 GC-DMS Methodology
The GC-DMS breath analysis method was developed to mirror as closely as possible the
method optimized on the GC-MS system. Breath sample collection and SPME
adsorption conditions were identical to those described for the GC-MS system
previously. Compounds were separated by gas chromatography (HP5890) using a DB-
WAXetr capillary column, 5 m length x 0.25 mm i.d x 0.25 m film thickness, with a 2.0
ml/min column flow. The microDMx from Sionex was used for sample detection. The
split/splitless injector was also operated at 250°C with a purge flow of 47.9 ml/min and
24:1 split ratio. Column temperatures were programmed identically as they were for the
GC-MS system described earlier. Refer to Section 2.3 and Table 2 for further
information.
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3 RESULTS
3.1 Preliminary Breath Experiments
These preliminary results are not the product of particular experiments for method
development or signal characterization. However, they were a required to gain a basic
understanding of the nature of breath samples collected with our protocol. This included
an analysis of ambient air, elucidation of background due to the breath collection
apparatus, as well as initial qualitative studies of breath samples. Preliminary
experiments served several purposes: 1) to provide a means to verify that GC-MS
results were consistent with those found in literature, 2) to determine if sample collection
bags could be reused throughout the study, and 3) to identify signal background and
determine its origin.
Signal analysis was performed with ChemStation® software and the automated mass
spectral deconvolution and identification system (AMDIS). For an initial study of breath
compounds and signal contamination from background, 15 samples from a single
individual were taken on different days with variation in the time of collection. Ambient air
(n=5) and sample collection apparatus blanks (n=3) were taken. Typical chromatograms
of each are shown in Figure 12 with corresponding chemical identifications listed in
Tables 3-5.
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Figure 12: Representative chromatograms for ambient air (top), breath collection apparatus (middle), and
breath sample (bottom) -- peaks identified in Tables 3, 4, and 5 respectively.
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Table 3: Compound identifications from ambient air chromatogram, Figure 12 (top)
Compound Peak no. Retention time (min) Match
Cyclotrisiloxane, hexamethyl- 1 1.42 96
Tetrachloroethylene 2 2.875 98
Cyclopentasiloxane, decamethyl- 3 6.025 93
Cyclohexasiloxane, dodecamethyl- 4 7.87 93
Cycloheptasiloxane, tetradecamethyl- 5 9.493 89
Ethanol, 2-(2-butoxyethoxy)- 6 13.099 91
Propanoic acid, 2-methyl-, 3-hydroxy- 7 14.232 85
2,4,4 trimethylpentylester
2,2,4-Trimethyl-1,3-pentanediol diisobutyrate 8 14.552 85
Diethyl Phthalate 9 22.859 95
Table 4: Compound identifications for breath apparatus chromatogram, Figure 12 (middle)
Compound Peak no. Retention time (min) Match
Cyclotetrasiloxane, octamethyl- 10 2.412 96
Cyclopentasiloxane, decamethyl- 11 6.025 74
Cyclohexasiloxane, dodecamethyl- 12 7.87 93
Acetamide, N,N-dimethyl- 13 8.769 96
Cycloheptasiloxane, tetradecamethyl- 14 9.493 90
Phenol 15 17.367 97
Table 5: Compound identifications for breath sample chromatogram, Figure 12 (bottom)
Compound Peak no. Retention time (min) Match
Cyclotetrasiloxane, octamethyl- 16 2.454 95
Cyclopentasiloxane, decamethyl- 17 6.052 94
D-Limonene 18 6.433 94
Cyclohexasiloxane, dodecamethyl- 19 7.891 93
Acetamide, N,N-dimethyl- 20 8.786 94
Cycloheptasiloxane, tetradecamethyl- 21 9.507 90
Phenol 22 17.416 97
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3.1.1 Identification of breath VOCs by GC-MS
Analysis using standard peak integration resulted in average detection on the order of
280 discernible peaks in the chromatograms of breath (n=56). Many of these peaks were
not present in chromatograms of ambient air or the sample collection apparatus and
therefore resulted from exhaled breath samples. Several breath compounds were found
at low signal levels compared to compounds identified in Figure 12. Figure 13 is an
expanded view of a chromatogram of breath and is shown to provide a better
representation of breath compounds in the TIC.
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Figure 13: Representative chromatogram of breath.
Of the 15 breath samples studied of a single individual, 120 compounds were identified
with various degrees of certainty (Table 6). "Identified" compounds are classified as
those that met the requirement of having a spectral library match factor greater than 70
and were consistently found in at least 25% of samples. Match factor is described as the
simple dot product between a library spectrum and the spectrum of the peak being
identified [54]. A match factor of 100 represents a perfect match. Detected VOCs are
mainly of 8 types, which are alkenes, alcohols, alkanes, aldehydes, ketones, volatile
fatty acids, esters and other organic compounds. VOCs are grouped as either positive or
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negative alveolar gradient. Section 2.1 provides a definition of these terms and a brief
explanation of their physiologic significance.
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Table 6: Identified Breath VOCs
Breath Compound Retention time (min) Match
----- VC)Cs with positive alveolar gradients -----
Cyclopropane 1.044 89
Isoprene 1.143 77
Carbon disulfide 1.255 87
Dimethyl sulfide 1.303 87
Acetone 1.446 93
Dimethyl selenide 1.495 81
Octane, 2,2,6-trimethyl- 1.992 86
Ethanol 2.039 95
Sulfide, allyl methyl 2.235 73
3-Ethyl-3-methylheptane 2.38 81
1 R-a-Pinene 2.878 85
Octane, 2,6-dimethyl- 3.057 85
Bicyclo[3.1.0]hex-2-ene, 4-methyl-1-(1-methylethyl)- 4.447 85
3-Carene 5.533 92
3-Myrcene 5.953 90
DL-Limonene 6.421 94
Dodecane 6.436 76
Eucalyptol 6.501 88
Furan, 2-pentyl- 6.93 76
Bicyclo[3.1.0]hex-2-ene, 2-methyl-5-(1-methylethyl)- 6.965 79
Benzenemethanol, a,4-dimethyl- 7.009 72
1,4-Cyclohexadiene, 1-methyl-4-(1-methylethyl)- 7.038 85
Styrene 7.229 84
Benzene, 1 -methyl-2-(1 -methylethyl)- 7.336 86
Benzene, 1-ethyl-4-methyl- 7.462 71
Octanal 7.552 81
Tridecane 7.604 89
Butane, 2,2-dimethyl- 8.204 70
Allyl Isothiocyanate 8.411 75
Tetradecane 8.674 85
Nonanal 8.687 76
Benzene, 1,4-dichloro- 9.302 80
Acetic acid 9.361 95
Cyclohexanone, 5-methyl-2-(1-methylethyl)-, trans- 9.443 73
Pentadecane 9.726 76
a-Cubebene 9.766 72
Cyclohexanone, 5-methyl-2-(1-methylethyl)-, trans- 9.777 74
Decanal 9.814 77
1 H-Pyrrole, 1 -butyl- 10.039 70
Propanoic acid 10.278 93
Propanoic acid, 2-methyl- 10.625 90
Caryophyllene 10.904 77
Butyrolactone 11.358 85
Bicyclo[4.2.0octa-1,3,5-trien-7-ol 11.522 82
Heptadecane 11.89 75
Dodecanol 12.074 72
Naphthalene 12.529 82
Anisole, p-allyl- 13.648 89
Pentanoic acid 13.957 78
Naphthalene, 2-methyl- 14.093 82
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Table 6 (continued): Identified Breath VOCs
Breath Compound Retention time (min) Match
Phenol, 2,4-bis(1,1 -dimethylethyl)- 14.232 86
Hexanoic acid, 2-ethyl- 15.973 78
Benzothiazole 15.985 83
1,1 '-Biphenyl, 3-methyl- 19.109 86
1,4-Benzenedicarboxylic acid, dimethyl ester 21.43 94
Benzoic Acid 23.728 93
Indole 23.766 90
----- VCCs with negative alveolar gradients -----
Propene 1.054 86
Hexane, tetradecafluoro- 1.067 71
Pentane 1.135 74
Ethane, 1,1,2-trichloro-1,2,2-trifluoro- 1.137 85
Hexane, 2-methyl- 1.139 84
Hexane, 3-methyl- 1.153 85
Heptane 1.18 82
Cyanic acid, ethyl ester 1.254 79
Ethane, isocyanato- 1.254 79
Hexane, 2,4,4-trimethyl- 1.582 84
Heptane, 3,3,5-trimethyl- 1.671 85
Nonane 1.738 90
Pentane, 2,2-dimethyl- 1.757 90
Propane, 1-(methylthio)- 1.944 89
Isopropanol 1.975 93
Heptane, 2,2-dimethyl- 2.095 87
Pentane, 3-methyl- 2.144 78
Heptane, 2,2,4,6,6-pentamethyl- 2.498 88
Decane 2.6 86
1 -Propanol 3.243 93
Undecane, 2,8-dimethyl- 3.402 84
Pentane, 3-methyl- 3.459 74
Undecane 4.25 80
p-Xylene 5.466 84
Camphene 6.553 81
Benzene, 1,2,3-trimethyl- 6.806 75
1,3-Cyclopentadiene, 1,2,3,4,5-pentamethyl- 7.458 78
Nonane, 2-methyl-5-propyl- 7.519 74
2-Butanone, 3-hydroxy- 7.545 85
2-Propanone, 1-hydroxy- 7.743 88
Tritriacontane, 15,19-dimethyl- 8.198 71
Benzofuran, 4,5,6,7-tetrahydro-3,6-dimethyl- 9.686 79
1 -Hexanol, 2-ethyl- 9.715 95
Benzaldehyde 10.181 92
2-Nonenal 10.247 88
1 -Butanol, 2-methyl- 10.438 79
1 -Heptanol, 4-methyl- 10.438 82
1 -Pentene, 3,4-dimethyl- 10.448 75
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (la,2a,5a)- 10.527 82
Dimethyl Sulfoxide 10.588 88
Hexadecane 10.817 79
Butanoic acid 11.267 71
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Table 6 (continued): Identified Breath VOCs
Breath Compound
Menthol
Butanoic acid, 4-hydroxy-
Ethanone, 2-(formyloxy)-1 -phenyl-
3-Cyclohexene-1 -methanol, a,a4-trimethyl-
Benzaldehyde, 2,4-dimethyl-
Cinnamaldehyde, (E)-
Phenol, 2,4,6-tris(1,1 -dimethylethyl)-
Butylated Hydroxytoluene
1 -Dodecanol
2-Pyrrolidinone
Isophthalaldehyde
Ethanol, 2-phenoxy-
1 -Hexadecanol
5-Hydroxy-4-octanone
Butanoic acid, anhydride
Ethanone, 1 -(5-methyl- -phenyl-1 H-pyrazol-4-yl)-
1,4-Benzenediamine, N-(4-methoxyphenyl)-
p-lsopropenylphenol
Benzophenone
Pentanoic acid
Naphthalene, 2-methyl-
Retention time (min)
11.335
11.358
11.552
11.934
12.521
13.799
14.667
15.084
16.375/ 20.493
17.867
19.76
20.015
20.495
21.592
21.637
23.527
23.572
23.975
24.152
13.957
14.093
3.1.2 Sampling Bag Reusability
Sampling bags were cleaned and reused in these experiments. Cleaning was achieved
by heating the bag for 5 min at 37°C followed by purging with nitrogen gas for 5 min.
These steps were repeated an additional time to guarantee complete removal of
remaining contaminants and breath sample. Blank signals taken after bag cleaning were
compared to the acquired signals from new bag blanks and breath samples. Typical
chromatograms of the three signals are overlaid in Figure 14, and it appeared that
compounds present in the breath signal are absent in the signals from new and cleaned
bags. The figure is expanded to show the chromatograms between 6 and 10 min, and
chemicals from the breath have been identified.
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Figure 14: Overlayed chromatograms of breath sample (red), new bag (black), and cleaned bag (blue).
Labeled chemical peaks are: 1) DL-Limonene, 2) Eucalyptol, 3) 1,4-Cyclohexadiene, 1-methyl-4-(1-
methylethyl)-, 4) Benzene, 1-ethyl- 2,4-dimethyl-, 5) Tridecane, 6) Benzofuran, 4,5,6,7-tetrahydro-3,6-
dimethyl-
Quantitative analysis of the three samples revealed that 3.7% 1.3% of breath
chemicals were found at reduced levels after the bag was cleaned. 25% indole, 11%
Dodecane, and 1% DL-Limonene remained uncleaned from the bag. However, analysis
of the new bag chromatograms showed that trace amounts of these uncleaned
chemicals were also present, often at levels similar to or exceeding those found in
cleaned bags. Additionally, new bags, which were purged but not heat treated prior to
sampling, contained a greater number of breath chemicals. When levels in the new bags
were accounted for, it was found that breath chemicals remaining after cleaning
accounted for less than 0.1% of the signal seen in breath. The breath cleaning
procedure was therefore found to be a sufficient requirement to permit bag reuse.
3.1.3 Identification of Background
As noted in Table 6, breath compounds are classified as either positive alveolar gradient
or negative alveolar gradient. Alveolar gradient is a measure of the concentration of a
compound in breath relative to the concentration in the ambient environment. The
51
tr-"·"r)·-L"g··-8*1
significance of these gradients is discussed elsewhere in this thesis (Section 2.1).
Several compounds were identified in the blank and ambient air chromatograms that
were uniquely attributable to sources other than breath. These compounds were
considered background and are listed in Table 7. Figure 12 (bottom) shows that these
background compounds in the chromatogram significantly overwhelm breath compounds
which can barely be seen at all. Furthermore, comparison of ambient air to background
revealed three prominent compounds whose origins were determined to be from the bag
material itself since no other differences between samples could account for their
presence. Peaks corresponding to two of these compounds are labeled in the middle
graphic of Figure 12: (13) Acetemide, N,N-dimethyl, (15) Phenol. The other is acetic
acid.
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Table 7: Identified VOCs in breath sample background
Background Compound Retention time (min)
Carbon dioxide 1.04
Cyclotrisiloxane, hexamethyl- 1.492
Octane, 2,2,6-trimethyl- 1.977
Cyclotetrasiloxane, octamethyl- 2.412
Toluene 3.22
Cyclopentasiloxane, decamethyl- 6.025
1-Pentene, 4,4-dimethyl-1 ,3-diphenyl-1 -(trimethylsilyloxy)- 6.507
Pentasiloxane, dodecamethyl- 7.384
Ethaneperoxoic acid, 1-cyano-l-phenylpentyl ester 7.459
Cyclohexasiloxane, dodecamethyl- 7.87
Acetamide, N,N-dimethyl- 8.769
Formamide, N,N-diethyl- 9.043
Cyclotrisiloxane, hexamethyl- 9.189
Cycloheptasiloxane, tetradecamethyl- 9.493
Benzaldehyde, 2,4-bis(trimethylsiloxy)- 9.991
2,3-Butanedione 10.346
Ethanol, 2-(2-methoxyethoxy)- 10.802
Ethanol, 2-(2-ethoxyethoxy)- 11.15
Benzene, propoxy- 11.19
Acetic acid, phenyl ester 11.209
Cyclooctasiloxane, hexadecamethyl- 11.247
Benzaldehyde, 3-ethyl- 11.485
Benzaldehyde, 4-methyl- 11.485
Acetophenone 11.519
2-Pyrrolidinone, 1-methyl- 11.685
Cyclohexane, isothiocyanato- 11.775
Acetic acid, phenylmethyl ester 12.38
Benzenemethanol, a-methyl-a-(1 -methyl-2-propenyl)- 12.667
Diisopropylethylamine 12.797
Ethanol, 2-(2-butoxyethoxy)- 13.099
Cyclononasiloxane, octadecamethyl- 13.125
Butane, 1 ,2,4-trichloro-heptafluoro- 13.648
2,2,4-Trimethyl- 1,3-pentanediol diisobutyrate 14.552
N-Acetyl-S-(2-hydroxybutyl)-L-cysteine methyl ester 15.084
N-Formylmorpholine 15.303
Phenol 17.367
Quinoline, 1,2-dihydro-2,2,4-trimethyl- 19.655
Cyclooctasiloxane, hexadecamethyl- 20.137
Isopropyl Palmitate 21.336
Cyclononasiloxane, octadecamethyl- 22.032
Pentanedioic acid, (2,4-di-t-butylphenyl) mono-ester 22.306
Diethyl Phthalate 22.859
Cyclononasiloxane, octadecamethyl- 23.556
Benzene, 1,3,5-tri-tert-butyl- 23.825
Cyclononasiloxane, octadecamethyl- 25.708
Dibutyl phthalate 27.611
53
3.2 Method Development
3.2.1 Selection of SPME Coating
The sensitivity and selectivity of the four types of coatings to breath VOCs were
evaluated. Each fiber extracted only a fraction of the 120 identified breath VOCs;
average extraction (with percentage of total compounds) for each fiber is as follows:
CAR/PDMS 29(24%), CW/DVB 28(23%), PDMS/DVB 38(32%), DVB/CAR/PDMS
43(36%). Table 8 summarizes the 22 breath target compounds extracted most
frequently by all fibers and the frequency that each was detected.
Table 8: Most frequently extracted breath VOCs (n = 12 samples)
Target Breath Compound Frequency
Acetone 100%
Limonene 100%
Propanoic acid 100%
Benzene, 1-methyl-2-(1 -methylethyl)- 92%
Indole 92%
Sulfide, allyl methyl 83%
Pentanoic acid 75%
Propanoic acid, 2-methyl- 75%
Tetradecane 75%
Tridecane 75%
2-Pyrrolidinone 67%
Benzene, 1,4-dichloro- 67%
Benzenemethanol, a,4-dimethyl- 67%
Caryophyllene 67%
Undecane 67%
Ethanone, 2-(formyloxy)-1 -phenyl- 58%
Pentadecane 58%
3-Carene 50%
Butylated Hydroxytoluene 50%
Dodecane 50%
13-Myrcene 50%
Dimethyl sulfide 50%
Triplicate samples were taken for each fiber. The 22 compounds were quantitated to
asses the extraction efficiency of each fiber. For more meaningful comparison, the
corrected area response of each analyte was normalized on a scale from 0 to 100 and
plotted in groups for each target VOC (Figure 15). The SPME coating that achieved the
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largest extraction for a target compound received a score of 100. The remaining fibers
were assigned scores representing the percent of analyte extracted relative to the
largest extraction. PDMS/DVB had the highest extraction capability in nine of the
compounds. CW/DVB was superior to the other coatings for the extraction of only one
compound, indole. CAR/PDMS and DVB/CAR/PDMS were each found to be most
efficient at extracting six of 22 tested breath compounds.
relative extraction efficiency
0 2C 40 60 80 100
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Figure 15: Relative extraction efficiency of SPME coatings to breath VOCs
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3.2.2 SPME Extraction Conditions
Equilibrium is a condition when the concentrations of compound in the collection bag
and on the SPME fiber do not change. The objective of SPME extraction is to reach
distribution equilibrium in the system. However, in complex samples such as breath,
what is found is that analytes compete for active sites on the solid porous polymer phase
the divynlbenzene in PDMS/DVB fibers. Therefore, at longer extraction durations
compounds in the breath matrix are displaced by other compounds for which the fiber
has greater affinity. The optimal time for extraction time may not be the equilibration time
if it is desirable to limit the effects of competitive displacement.
In order to determine the optimal duration for SPME sampling, extraction was monitored
by plotting area response against fiber exposure time. Extraction profiles were
established for the 22 most frequently detected chemicals, determined in Section 3.2
(Table 8). Compounds can be classified into four groups based on their observed
extraction characteristics to prolonged extraction duration: increasing with equilibrium
(IE), increasing with no equilibrium (INE), decreasing with equilibrium (DE), and
decreasing with no equilibrium (DNE). The 22 compounds monitored were distributed
across all extraction characteristics except for DNE. Representative plots of extraction
profiles for each class are given in Figure 16: propanoic acid for IE, undecane for INE,
and acetone for DE. An extraction time of 30 minutes was chosen for subsequent
experiments because it seemed to best balance the competitive adsorptions of VOCs in
breath. At this duration, extracted acetone decreased to 52% of its maximum, propanoic
acid reached 92% of its equilibrium value, and undecane increased to 12 times its value
initially extracted at 1 min (Figure 16).
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Figure 16: Representative extraction profiles for three classes observed.
(n = 3) + standard deviation. IE (top), INE (middle), DE (bottom)
Values are given as the average
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3.2.3 GC-MS Settings
In order to develop a gas chromatography temperature profile, performance was
evaluated against three parameters:
1. Breath compound peak resolution
2. Overall signal-to-noise ratio
3. Analysis runtime
The left-hand panels in Figure 17 show the oven profiles that were developed and
compared to optimize the stated goals. Although the retention time indexes are not
constant due to different temperature profiles, the region between 6 min and 18 min in
the resulting plots was targeted for improvements in component resolution. The
sequence of TICs as subsequent methods showed marked improvement in signal
separation. The signal noise levels were also monitored. A higher signal noise is
associated with a higher noise level value. The final method chosen was method 5.
While it did not achieve superior results in all performance measures, this was the
method that provided the optimal balance between noise, run time, and peak resolution.
Compounds were the most separated with this method and a noise level of 19 was the
second lowest observed. Method 1 with a noise level of 18 had a run time of 40 min,
which was less desirable than 28 min for sample analysis achieved with method 5.
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Abundance
method 1
initial temperature: 50 °( (5 min)
25 °C/min to 100 °C (4 min)
ramp: 10 °C/min to 150 °C (7 min)
5 °C/min to 210 °C
final temperature: 210 "'( (5 min)
m/z range: 50-5(0
run time' 40 min
noise level: 18
Abundance
Abundance
method 3
initial temperature: 50 °C (5 min)
25 °C/rnin to 100 °C
ramp: 10 °C/rnin to 150 °C (5 min)
5 °C/min to 210 °C
final temperature: 210 °C (5 min)
m/z range: 38-400
run time: 28 min
noise level: 23
Figure 17: GC temperature profiles and the resulting total ion chromatograms (TICs). Adjustments to the
oven temperature programs result in improved compound resolution.
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Figure 17 (cont): GC temperature profiles and the resulting total ion chromatograms (TICs).
3.2.4 Sample Storage Time
The results of sample stability at different storage durations did not reveal significant
changes in the observed response to breath VOCs. When 72 hour holding was
compared with 30 minute holding, observed breath sample responses for well known
VOCs including acetone, propanoic acid, undecane, tridecane, -Myrcene, ethanone, 2-
(formyloxy)-l.-phenyl-, and indole changed an average of 42.5%. Storage for 24 hours
resulted in an average 29.8% change from baseline. These results appear to indicate
that these compounds should not be stored for long periods of time (Figure 18).
However, the above results were statistically qualified using a Student t-test with a 95%
confidence. Comparisons were made between the mean values of samples analyzed
after 30 min (n = 3) to the mean values of stored samples at (6, 12, 24, 48, 72 hrs).
Although the average trends are suggestive, the results were not statistically significant
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(Student t-test, a = 0.05). The only VOC that achieved significance was tridecane. The
37.6% decline in response from 30 min to 72 hrs was statistically significant with
p = 0.029.
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Figure 18: Storage stability of breath VOCs. Results are plotted as the average + the standard
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3.3 Breath Characterization
3.3.1 Single Individual Variability using GC-MS
In order to understand the possible variability in exhaled breath, the target VOCs that
were observed with the greatest frequency (section 3.2.1) were analyzed in ten samples
from a single individual. The frequency of breath compounds in these samples is
summarized in Table 9. Although the sources of variability were not determined,
variability from adsorption to sample collections bags, differences in SPME fiber
extraction conditions, the time of day samples were taken, and even stress levels could
all be contributing factors.
Table 9: Frequency of target breath VOCs in single individual (n = 10 samples)
Target Breath Compound Frequency
Benzene, 1 -rnethyl-2-(1 -methylethyl)- 100%
Benzenemethanol, a,4-dimethyl- 100%
Limonene 100%
Tridecane 100%
Acetone 90%
Butanoic acid 90%
Indole 90%
Dodecane 80%
Tetradecane 80%
Ethanone, 2-(formyloxy)-1-phenyl- 70%
13-Myrcene 70%
2-Pyrrolidinone 60%
Propanoic acid, 2-methyl- 60%
Undecane 50%
Benzene, 1,4-dichloro- 40%
Butylated Hydroxytoluene 40%
Sulfide, allyl methyl 40%
3-Carene 20%
Caryophyllene 20%
Propanoic acid 20%
Dimethyl sulfide 0%
Pentadecane 0%
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Corrected area responses were used to monitor variations in exhaled quantities of these
compounds. Table 10 provides the mean corrected area responses for each with
standard deviation and % deviation. The % deviation is provided as a means to compare
the variability in different compounds. VOCs with higher % deviation have a greater
degree of variability. Some of the compounds exhibited high degrees of variability, with
% deviation 100%: Caryophyllene (117.3%), DL-Limonene (102%), and 3-Carene
(100%). However, only DL-Limonene should be noted for this observation. The others
were not observed with enough frequency to be significant. The results for Limonene,
however, are significant since it was found in all breath samples analyzed.
Table 10: Target breath VOC variability in single individual (n = 10 samples)
corrected area response
standardTarget Breath Compound mean deviation % deviation
Benzene, 1 -rnethyl-2-(1 -methylethyl)- 13045.7 10010.7 76.7%
Benzenemethanol, a,4-dimethyl- 7571.1 5120.0 67.6%
Limonene 92090.6 93937.9 102.0%
Tridecane 8395.5 3415.2 40.7%
Acetone 22054.8 13650.0 61.9%
Butanoic acid 6881.0 1800.3 26.2%
Indole 7093.2 2683.2 37.8%
Dodecane 6042.5 2963.2 49.0%
Tetradecane 7036.9 5697.1 81.0%
Ethanone, 2-(formyloxy)-1-phenyl- 3334.1 1250.1 37.5%
13-Myrcene 5596.9 3378.2 60.4%
2-Pyrrolidinone 10804.8 2756.9 25.5%
Propanoic acid, 2-methyl- 1989.5 826.0 41.5%
Undecane 3374.0 795.2 23.6%
Benzene, 1,4-dichloro- 2285.0 857.4 37.5%
Butylated Hydroxytoluene 3347.6 2942.2 87.9%
Sulfide, allyl methyl 4690.0 3240.5 69.1%
3-Carene 27423.0 27418.8 100.0%
Caryophyllene 5039.1 5913.0 117.3%
Propanoic acid 6984.1 3315.3 47.5%
Dimethyl sulfide 0.0 0.0 0.0%
Pentadecane 0.0 0.0 0.0%
Correlation, Euclidean distance, and Manhattan distance provided a numerical measure
of the similarity between the ten breath signals. For comparison, the same distance
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calculations were applied to ambient air and background samples. Table 11 reports the
distance from the sample average for each group. It is clear that breath samples have
more variability than ambient air. However, the scores for breath are not statistically
different from those for background using these scoring methods (pairwise Student t-
test, a = 0.05).
Table 11: Distance calculations for breath, air and background signals.
Euclidean score Manhattan score Correlation score
u0i:: breath air background breath air background breath air background
2.932E+07 1.277E+06 2.278E+07 7.027E+08 2.048E+07 2.543E+08 0.37726 0.00517 0.44044
*, ';:1-- m: . 3.501 E+07 2.063E+06 1.179E+07 4.944E+08 1.825E+07 1.385E+08 0.32015 0.00855 0.10626
3.193E+07 2.508E+06 1.213E+07 4.388E+08 2.041 E+07 1.321E+08 0.24909 0.00623 0.12265
. . 3.094E+07 4.807E+08 0.23915
2.28 7E+07 3.632E+08 0.30016
2.346E+07 3.410E+08 0.30439
2.784E+07 3.721 E+08 0.34805
4.378E+07 6.118E+08 0.36984i . : . 2.986E+07 4.494E+08 0.33276
5.633E+07 6.518E+08 0.42015
3.313E+07 1.949E+06 1.557E+07 4.906E+08 1.971E+07 1.750E+08 0.32610 0.00665 0.22312
Exploratory principal component analysis (PCA) was also performed to provide a
representation of the variability in the three data sets (Figure 19). From the PCA results
we can observe that ambient air is tightly clustered together while background and
breath samples are more spread out.
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Figure 19: Plot of PCA scores for breath from a single individual, ambient air, and collection apparatus
background
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3.3.2 Inter-individual Variability
When more than a single individual is considered, the number of breath compounds
identified can reach over three thousand [24]. The final experiment of this thesis aimed
to look at the variability in breath from multiple subjects using our unique sampling
methodology. Rather than providing a qualitative listing of compounds, a quantitative
measurement of signal similarity was calculated. Correlation, Euclidean and Manhattan
distances applied previously to single individual samples were used as the numerical
metrics. PCA was used here to identify and visualize any trends in the data.
For this study, 7 individuals were solicited for breath samples. The sample selected was
too small to represent the adult population, but represents one of the first SPME-GC-
DMS analyses done on control human subjects. The mean age was 25 years old and
there were 2 females and 5 males. All of the subjects were apparently healthy and 2 of 7
were known smokers. Samples were collected using collection methods and extracted
with SPME (PDMS/DVB) as outlined above followed by analysis on GC-MS and GC-
DMS systems according to the following parameters. Plots are shown in figures 21
through 25 and numerical results are reported in tables 12 through 15.
3.3.2.1 GC-MS Total Ion Chromatogram Variability
Euclidean, Manhattan, and correlation metrics were applied to total ion chromatograms
(TICs). Less variation is observed across multiple subjects than within a single individual
(Student t-test, p = 0.0078). Unique peaks were observed between individuals, but
variability was not tremendous under the sampling and analysis conditions.
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Table 12: Distance scores for single and multiple subject studies
Euclidean score Manhattan score Correlation score
single subject multiple subjects single subject multiple subjects single subject multiple subjects
:;,1 '::! 2.932E+07 1.739E+07 7.027E+08 2.259E+08 0.37726 0.012
j i,, 3.501 E+07 3.599E+07 4.944E+08 2.490E+08 0.32015 0.059
3.193E+07 1.230E+07 4.388E+08 1.643E+08 0.24909 0.004
3.094E+07 1.077E+07 4.807E+08 2.308E+08 0.23915 0.005
2.287E+07 1.156E+07 3.632E+08 2.298E+08 0.30016 0.006
. l 6¢ ^ 2.346E+07 1.577E+07 3.410E+08 2.123E+08 0.30439 0.008
2.784E+07 3.721 E+08 0.34805
4.378E+07 6.118E+08 0.36984
2.986E+07 4.494E+08 0.33276
5.633E+07 6.518E+08 0.42015
.:i' ' . 3.313E+07 1.730E+07 4.906E+08 2.187E+08 0.32610 0.01579
Principle component analysis supports this finding (Figure 20). The TICs from multiple
subjects were more tightly clustered than were the corresponding measurements for a
single individual. Also, a peculiar finding was that ambient air, breath and background
were all clustered away from the multiple subjects. This unexpected outcome suggests
that some experimental bias has affected these results.
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Figure 20: Plot of PCA scores for breath from a single individual, breath from
air, and collection apparatus background
multiple subjects, ambient
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Figure 21 shows representative chromatograms from the single and multiple subject
studies. Although TICs from section 3.1 suggest the largest peaks result from
background chemicals, the two representative TICs here do not have backgrounds that
match. Moreover, the abundance of peaks for phenol and acetemide, N,N-dimethyl- are
noticeably greater in the typical chromatogram of a subject in the inter-individual
variability study. At the beginning of this study, a new set of sample collection bags were
ordered. It appears from this figure that the release of tedlar VOCs is more substantial in
the new set as more prominent peaks are produced. This confounding finding makes
comparison between the two data sets more difficult.
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Figure 21: Typical chromatograms of breath from signal individual (top) and typical breath from one of the
multiple individuals (bottom).
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3.3.2.2 GC-DMS Feasibility and Total Ion Abundance Variability
As this is one of the first examples of GC-DMS analysis of breath it will be important to
show that there is not only consistency between sample but that also the expected
variation is also present. Representative DMS spectra are shown in Figure 22. Breath
from two representative subjects are compared at 3 different times during the run of our
standard method. The plots illustrate how there are many similarities between the
acquired signals but also illustrate that the differences between individuals can be
appreciated qualitatively.
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Figure 22: Representative SPME-GC-DMS spectra from 2 subjects highlighting the similarities and
differences between acquired spectra. Subject 705 (top) and subject 711 (bottom). Colors represent signal
intensity at the corresponding time and compensation voltage, and scaling is the identical for each plot.
In order to perform numerical analysis, a signal representation analogous to total ion
chromatogram (TIC) was created. Total ion abundance (TIA) is the result of summing
intensities across all compensation voltages in the positive ion DMS spectrum. Two
representative TIAs are shown in Figure 23.
71
r
5 6 7
0 1 2 3 4 5 6
time (min)
Figure 23: Total Ion Abundance signals from SPME-GC-DMS analysis
7 8
of breath from two subjects.
Distance measurements were performed resulting in the following matrices. Here the
entire matrices are given for each distance function to illustrate how some breath TIAs
are more related than others. Each subject pair produces a single score. Therefore, only
scores in the lower triangle need to be observed. The distance to the sample average is
also provided in the right most column of the matrix.
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Table 13: Euclidean distance measurements of breath TIAs
subject number
e701
e702
e703
e704
e705
e711
e713
e701
0
120.28
134.06
130.03
131.82
91.82
107.97
e702
0
44.82
77.65
65.76
52.19
89.16
e703
0
87.57
81.39
61.14
108.95
e704
0
58.36
86.25
77.91
e705
0
76.83
85.47
e711
0
85.50
e713
0
distance
to average
93.73
41.73
59.24
56.33
52.95
38.23
61.94
Table 14: Manhattan distance measurements of breath TIAs
distance
subject number e701 e702 e703 e704 e705 e711 e713 to average
e701 0 1627.30
e702 2346.70 0 923.55
e703 2906.70 1029.70 0 1470.20
e704 2005.90 1775.80 1990.80 0 1224.50
e705 2211.60 1437.40 1988.50 1206.60 0 1008.50
e711 1878.60 988.16 1513.60 1938.20 1438.80 0 869.02
e713 1720.10 1983.50 2548.10 1451.90 1727.50 1991.40 0 1337.80
Table 15: Correlation coefficients for breath TIAs
correlation
subject number e701 e702 e703 e704 e705 e711 e713 with average
e701 0 0.202
e702 0.428 0 0.132
e703 0.356 0.101 0 0.089
e704 0.690 0.586 0.542 0 0.376
e705 0.831 0.503 0.517 0.492 0 0.463
e711 0.258 0.158 0.066 0.612 0.551 0 0.084
e713 0.501 0.496 0.506 0.457 0.731 0.505 0 0.290
These distance functions show that there was inter-sample variability (Table 13-15).
Principle component analysis verifies this and one observation is found in the left half of
the plot (Figure 24). This outlier is subject e701, the same subject that had the largest
Euclidean and Manhattan distances when compared to other subjects. The TIA for this
sample is shown in Figure 25.
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Figure 24: Plot of PCA scores for breath from multiple individuals.
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Figure 25: Total ion abundance of breath sample from subject e701
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4 DISCUSSION
4.1 Preliminary Breath Experiments
The purpose of these preliminary experiments was to establish that our GC-MS method
could be used to identify breath compounds, to ensure that our protocol supported the
reuse of sampling bags, and to identify components of the breath sample background.
Discussion is also provided here regarding the collection method and materials used in
this thesis.
4.1.1 Breath Collection Method
One of primary advantages of breath analysis is that it has the potential to be a more
convenient and non-invasive way to obtain medically relevant measurements. As simple
as it is to breath, obtaining proper samples of breath for analysis is still a challenge.
There are currently no accepted methodologies to collect breath for analysis. And one
limiting feature is that there are many opportunities for contamination from the
environment, from the collection apparatus, and even from airways inside the body.
Some researchers employ lung washouts with pure air [9, 34], some require subjects to
breath into complex instruments [31, 55], and others suggest subjects to hold their
breath for between 20 and 60 seconds before giving a sample [51]. While accuracy is
sought, so are convenience and a method that would be practical in the clinical setting
where breath analysis will be carried out. The collection protocol established in this
research aimed to balance accuracy with convenience. In order to increase accuracy,
once the method had been developed, it did not change during the study although new
information (e.g. reduction of background with bag purging) provided evidence that it
could be modified to improve results.
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4.1.2 Identification of breath VOCs by GC-MS
In preliminary studies, 120 compounds were identified in breath although many more
compounds were found that did not pass identification criteria. In other investigations
where the primary objective was to establish the full range of compounds in normal
human breath, over 3000 VOCs were observed [24]. Possible reasons for the
discrepancies between results are: 1) breath samples were directly concentrated using
sorbent tubes before analysis with GC-MS as opposed to SPME extraction from
sampling vessels, 2) the collection and analysis methods employed permitted a greater
number of compounds to surpass the threshold for identification, and 3) the study
analyzed breath samples from 50 individuals while only a single subject was used for
compound identification in this thesis. However, the study reported mean detection of
204 compounds for single individuals - a number more consistent with the results
observed here.
Additional similarities exist between VOCs identified in previous studies and the present
work. Most notably, the majority of the 120 compounds identified here were found
among the most frequently observed constituents of breath [24, 31]. Determination of
positive and negative alveolar gradient VOCs was also congruent to previous results.
This work represents one of the few elaborations of breath VOCs using solid phase
microextraction and the observed similarities to past results serve to validate the
experimental parameters determined in this thesis.
One of the difficulties in compound identification was achieving match factors above our
threshold of 70. Peak spectra can be "contaminated" with extraneous ion masses which
can arise from co-eluting compounds, column bleed, and ion-chamber contaminants
[54]. These masses can make it difficult to perform automated compound identification.
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This work represented the application of AMDIS for compound identification in addition
to more traditional methods used in Chemstation software. AMDIS, developed in 1998,
is a technique that extracts "purified" spectra from peaks in the total ion chromatogram
(TIC) for comparison with reference libraries [56]. This permits reliable detection
performance at very low signal levels and for overlapping compounds in the TIC. These
features were particularly useful as many extracted breath compounds provided only low
signal amplitudes. Moreover, AMDIS aided in the identification of coeluting breath
compounds and helped expose regions of the TIC that required greater resolution.
4.1.3 Breath Collection Materials
In most studies, breath was collected in inert tedlar bags or stainless steel
electropolished canisters [3, 57]. The canisters have some advantages in that they are
reactive with few compounds and they prevent sample cross contamination much more
effectively. However, the per unit cost alone makes them very impractical as disposable
collection vessels in medical applications. Tedlar, on the other hand, has the significant
advantage of being disposable.
It is questionable whether tedlar is the most suitable material for gas sampling. Though
it is relatively inert, there is evidence of off gassing and adsorption of some volatile
species to the bag walls. Tedlar bags release acetic acid and phenol and greatly adsorb
indole and skatole, thereby having the potential to bias analysis. However, because a
better material for gas sampling has not been proposed, Tedlar is still the material of
choice.
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4.1.4 Sampling Bag Reusability
Because exploratory experiments required many sample collections, we wanted to
determine whether the breath collection bags could be cleaned and reused. The
cleaning protocol for breath sampling bags revealed adequate cleaning of breath
compounds and sample carryover within tolerable limits at less than 0.1%. It was
determined that "uncleaned" breath compounds like Indole, Dodecane, DL-Limonene
are also found in the ambient environment, making it questionable whether the observed
compounds resulted from poor cleaning performance.
Additionally, an interesting observation is that the percent of VOCs from uncleaned bags
falls within the normal variability observed as day-to-day variations (Table 10). Although
it was not established as part of this thesis, the percent deviation of compounds for a
single individual could result from other non-physiological sources such as imprecision in
extraction conditions, storage stability, or instrumentation.
The scaling of figure 12 conceals another unexpected finding from this experiment.
Comparison of new bags and cleaned bags reveals a reduction in contaminating peaks
originating from tedlar material (Figure 26). This finding further supports the identification
of tedlar as the source of phenol and acetemide, N,N-dimethyl and demonstrates that
other background peaks come from other sources in collection and analysis. Therefore,
with application of this cleaning protocol some background can be removed.
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Figure 26: Reduction of phenol chromatographic peak from bag cleaning protocol. Phenol peak in new bag
(black). Phenol peak in cleaned bag (blue).
4.1.5 Identification of Background
We identified a number of compounds that are not native to human exhaled breath but
present in the breath signal nonetheless. It was important to identify these compounds
initially so that's conclusions would not be based on their quantitation in remaining
experiments. Several background components were found in large abundances and are
identified in figure 12 and its supporting tables. Siloxane compounds such as
cyclopentasiloxane, decamethyl are believed to arise due to bleed from the
chromatographic column polymer, SPME fiber, and/or septa from either the GC inlet or
sampling apparatus. Acetemide, N,N-dimethyl and phenol were previously attributed to
the tedlar material.
Phenol, a constituent of the background signal, was used as a normalizing factor in
quantitation (Section 2). It is important to acknowledge that area response correction by
phenol is not a widely-used technique. Internal standards are normally used for this
purpose. However, the evidence showing phenol as a consistent presence in Tedlar
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bags was found in literature, and the results when corrected area response was applied
were consistent with results reported by others in literature [28].
4.2 Method Development
4.2.1 SPME coating selection
One major drawback to SPME is that it necessarily excludes certain types of compounds
in the breath matrix from analysis. This is minimized by having many available fiber
coatings and choosing the one most responsive to breath. While CAR/PDMS would be
the fiber of choice for its high affinity to the types of compounds in breath, evidence
supporting the selection of PDMS/DVB highlights the importance of relying on separation
and analysis experience for fiber coating selection.
The choice of PDMS/DVB as the optimal coating for the extraction of breath VOCs was
determined according to which had selectivity for the greatest number of compounds
and highest sensitivity. High selectivity was a reasonable aim since we desired a method
to capture and analyze the widest breath profile possible. Because VOCs are found in
nanomolar concentrations, choosing a coating with high sensitivity provided more
complete extraction of poorly extracted VOCs and produced more prominent signals with
improved signal-to-noise characteristics.
Nevertheless, two shortcomings of this approach can be identified. First, with only 120
targeted compounds for selectivity analysis, determination of the best coating for this
purpose was based on a small fraction of the over 3000 previously identified VOCs in
human breath. The 120 compounds were among the most frequently observed in past
studies, and the analysis of selectivity was based on collections from the same
80
individual. So, while this work establishes superior selectivity with PDMS/DVB for a
single subject, we did not necessarily establish the optimal coating for extraction of the
entire diversity of compounds observed in breath.
Second, the 22 breath compounds targeted for sensitivity analysis represented further
reduction of the 120 VOCs identified here. This was done intentionally as quantitative
analysis for 120 VOCs would have required a much greater investment of time and
resources. Efforts were made to establish that the 22 target compounds represented a
diverse set of VOCs, but ultimately, selection of the targets was based on observation
frequency and not physical or functional considerations. Moreover, the compounds most
efficiently extracted by PDMS/DVB coating did not represent a wide diversity even from
among the compounds selected. So, while sensitivity was established for many of the
targeted compounds, it was not necessarily established whether PDMS/DVB would
provide greater sensitivity to the diversity of compounds observed in breath. Alkanes,
such as dodecane, tridecane, pentadecane, and undecane, were well extracted by the
PDMS/DVB fiber, but overall the DVB/CAR/PDMS coating extracted these compounds
with greatest efficiency. Carboxylic acids, sulfides, and the single ketone investigated
were better extracted by the CAR/PDMS coating.
Additionally, the DVB/CAR/PDMS coating selected 36% of the 120 compounds versus
32% for PDMS/DVB making it a very close second choice for fiber. PDMS/DVB was
selected because overall its sensitivity performance was preferred over the slightly
superior selectivity found with DVB/CAR/PDMS. Compounds like -Myrcene and 3-
Carene for which PDMS/DVB demonstrated superior sensitivity were extracted 2.6x and
6.7x more effectively. Furthermore, this resulted in signal-to-noise improvements for
these compounds of 1.8x and 3.3x, respectively.
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4.2.2 Extraction Conditions
The profiles of the three observed extraction characteristics in Figure 13 demonstrate an
important concept in solid phase microextraction: that for porous polymer coatings,
competitive adsorption can cause analyte displacement and a reduction in extraction
capacity for lower affinity compounds at equilibrium [58]
Ideally we would like to reach equilibrium between the breath sample matrix and the
fiber. However, because we are looking at a complex matrix with many VOCs, definition
of an appropriate adsorption time is difficult. Some analytes have high affinity to the fiber
initially, but as time increases they may be competitively displaced reducing their
concentration extracted on the fiber. This is may be an explanation for the response
seen with by acetone and propanoic acid which decrease the longer extraction is held.
When shorter than equilibrium extraction times are used, care must be taken to ensure
that conditions are kept precisely constant for each sample. If compounds are not able to
equilibrate, an increase in temperature or a decrease in time may have a significant
effect on the relative amounts extracted from the sample. Compounds in the breath
matrix were found to fall into 3 different categories. Those that do not reach equilibrium
but continue to increase over the durations examined, those that reach equilibrium some
time between 1 and 120 min, and those that were competitively selected out but reach
equilibrium at amounts less than initially extracted. To find balance between these the
conflicting equilibrium categories, an extraction time of 30 min was selected.
Another important parameter to optimize is extraction temperature. A preliminary
investigation was carried out to explore the effect of extraction temperature. 37°C was
preferred and chosen as the standard extraction temperature because of its
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physiological significance as the temperature of gases in the alveoli along with the
following reasons. Firstly, the higher temperature ensures the evaporation of condensed
water from the Tedlar) bag surface. VOCs that would otherwise be trapped by the
condensed water are released at this temperature leading to improved extraction [34].
Secondly, it was reasoned that higher temperatures than 37°C could potentially damage
the bag material or cause more background volatiles to off gas from the bag wall.
Also important for the study of breath is that PDMS based coating do not concentrate
major breath components like oxygen, carbon dioxide, or water vapor very well allowing
more extraction capacity for VOCs in breath.
4.2.3 GC-MS Settings: resolution of pentane and isoprene
Multiple past studies have focused on single compounds as disease markers, but few
have attempted to enumerate the many compounds in breath and test their fitness for
disease detection. It is the goal of this project to develop a breath analysis technique that
accounts for the great diversity in breath. However, because acute cardiac distress
populations have been shown to produce higher levels of breath pentane and isoprene,
it was of particular interest to monitor these markers in our study. The methods we
developed were capable of detecting pentane and isoprene with match factors of 74 and
89, respectively. The VOCs were extracted by SPME and analyzed by mass
spectroscopy, but AMDIS was required to deconvolve the signals in the resulting TIC,
highlighting that separation with gas chromatography was still insufficient.
While we were able to achieve good separation between many of the chemicals present
in breath with oven parameters, we were unable in the timeframe of this study to
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establish a temperature program to separate pentane and isoprene from each other in
our first round of studies. Quantitation on these compounds was difficult due to their
coelution in chromatograms. Separation is more easily achieved with Poraplot Q and
Poraplot U columns, but these columns are not of practical use for other VOCs in human
breath. Figure 27 demonstrates how peaks in the TIC for pentane and isoprene merge
into one using our current method. Peak splitting, seen with acetone in the figure, is
common. However, separate ion components, representing two distinct compounds, are
found in the mass spectra around the retention time of 1.14 min.
time (min)
Figure 27: Coelution of pentane and isoprene in total ion chromatogram (TIC).
Although we were unsuccessful in resolving pentane and isoprene from one another in
GC-MS analysis, it is possible that they will be well separated in GC-DMS analysis.
Although component separation is primarily achieved by the GC, the nonlinearity of DMS
provides an additional level of separation that may allow resolution of these two
potentially important chemicals for disease detection. It was not possible to determine
pentane and isoprene separation with GC-DMS in this study as differences in column
length prevented correlation between GC-MS and GC-DMS spectra. However, this may
be possible in future studies.
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4.2.4 Sample Storage
As a first step to a field deployable device, samples obtained from the hospital will be
stored before analysis in the laboratory. This will allow us to perform proof-of-concept
experiments for biomarker determination. Recommended storage times vary in the
literature. Conclusion regarding an appropriate storage time was not determined in this
thesis. Previous studies of storage stability do not recommend storage beyond 6 to 9 hrs
[34, 59]. Without experimental evidence otherwise, it is recommended that samples be
stored for less than 9 hours. This poses a logistical problem for any sample collection
that must be done in future trials. However, with careful planning, it is simple to
overcome. Samples should not be collected unless arrangements can be made for
analysis within the recommended storage time. It is imperative that once samples are
collected that they be used in trials to determine possible biomarkers for disease.
Therefore, proper communication must be maintained between study centers and the
laboratory where analysis is to be performed. Limitations from storage instability may
result in enrollment reduction in future studies as some candidates for breath analysis
will not be considered due to timing constraints.
As noted in section 3.2.4, the trends from the storage stability study are suggestive.
Significance was limited by high variability and underpowered analysis. Although results
suggested sample instability at 24 hours with response changes of 29%, further studies
should be performed to asses the storage stability of the sampling system. Storage
durations greater than 9 hrs could greatly improve enrollment in future studies and
permit faster determination of disease biomarkers.
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4.3 Breath Characterization
The observed VOC variability in day-to-day experiments can be explained by two
possible reasons. First, the large degree of variability could be evidence of considerable
changes in breath composition from day to day. This has implications for future studies.
If the normal variability is so significant, biomarkers for disease detection will have to
produce changes above and beyond the normal variability in order to be identified and
used in disease diagnosis. The power of pattern recognition as a data analysis tool,
however, is to account for and eliminate normal variability seen across both diseased
and healthy populations. Pattern recognition algorithms only determine fingerprints
based on differences observed consistently in one group when compared to another
regardless of the magnitude of those differences.
On the other hand, the observed variability could be caused by analytical imprecision.
The breath profiles presented in Figure 16 identify two regions of extraction - an initial
concentrating phase where analytes are filling active sites of the divinylbenzene and an
equilibrium phase, where analyte concentrations remain stable. During the concentrating
phase extracted quantities of each compound are changing and the rate can vary
depending on polarity, molecular weight, and temperature. 30 min, an interval during the
concentrating phase for many VOCs, was chosen for extraction primarily because it
limited competitive displacement of compounds that had lower affinities for the active
sites. However, if the timing of extraction is not precise, extraction times in the
concentrating phase can lead to sizable changes in the quantities extracted and
observed. For example, if extraction is held 5 min longer (an increase of 17%),
undecane extraction could increase by approximately 2000 abundance units, nearly 60%
of its observed amount at 30 min. Very small error suggests that timing imprecision did
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not dramatically effect quantitation of undecane. However, this brief analysis
demonstrates the importance of extraction precision for proper quantitation. It should
also be noted that measurement errors for propanoic acid were not found to be nearly as
small.
If we think of breath compounds as signal and background compounds as noise, than
the numerical measurements evaluating single individual and inter-individual variability
all suffered from very poor signal to noise ratios. PCA plots that were presumed to
demonstrate variability probably resulted more from background artifact than from
variation in breath signal. The primary reason for this response can be traced to
fundamental principles underlying PCA and numerical measures of similarity. Each total
ion chromatogram is treated as a vector of features. So, the magnitudes of the
abundances at specific retention times are essentially multiplied. This assigns greater
weight to higher abundance features particularly if they correlate to high abundance
features in the compared chromatogram. What results is that background, instead of
breath dominates PCA and the numerical functions applied in this study.
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5 CONCLUSION
The research that makes up this thesis is part of a larger, multiphase study to determine
the diagnostic potential of breath analysis. In this work, a method was developed for the
analysis of human breath with Solid Phase Microextraction (SPME) and using both Gas
Chromatography- Mass Spectrometry(GC-MS) and Gas Chromatography- Differential
Mobility Spectrometry (GC-DMS) systems. The method was validated by techniques
previously described in literature. Several parameters of the collection and analysis
method were explored and optimized to meet the goals for the larger study. Specifically,
the aim is to develop a stand alone device for medical diagnostics. Future work on
bioinformatic modeling of the sensor output and biomarker discovery will also be needed
for future clinical trials. The needs of this bioinformatic approach were highly considered
in the development of a protocol for breath collection and sample analysis.
Breath is a complex compound mixture to analyze. From these studies, we determined
that attempts to concentrate and analyze breath are confounded by the complex
interactions of breath compounds with each other, and more importantly, with adsorptive
polymers. SPME extraction methods were gleaned from the literature and optimized to
concentrate trace levels of volatile organic compounds (VOCs) in breath. Part of the
attractiveness of SPME for breath analysis is that it is simple enough to be deployed in
field applications, which combined with DMS for fast analysis will allow breath analysis to
make its greatest impact on medical diagnostics.
This project also dealt with the characterization of breath using GC-DMS and GC-MS
systems. With GC-DMS, this research represented the first attempt to implement breath
analysis using SPME and GC-DMS. Preliminary investigation of the resulting signals
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demonstrated that a large signal can be obtained from these sample types greater deal
of information than has previously been seen with DMS analyzed samples. The potential
for disease detection from breath has not yet to been demonstrated although results
presented here using PCA and distance functions do show promise.
Characterization of breath using GC-MS revealed similar breath compounds to previous
research in the literature. Quantitative analysis demonstrated the need for rigorous
control of collection and extraction parameters to obtain reproducible results. SPME
extraction conditions, in particular, must be maintained within tight controls as slight
changes can dramatically affect results.
Comparison of signal variability in single individuals and between multiple subjects
revealed potential biases when PCA was applied. This highlighted the need for careful
correction of background in the future. The background includes contaminants from the
environment although it is sampling apparatus contamination that may be a significant
artifact.
The protocol developed in this thesis provides a robust signal suited for diagnostic
modeling, classification, and disease diagnosis. The combination of GC-MS and GC-
DMS in future analysis will provide an opportunity to validate the origin of identified
features of disease biomarkers. Solid phase microextraction, differential mobility
spectrometry, and the application of classification algorithms to these sensor outputs
have the potential to push the frontiers of breath analysis to a point that it may one day
be realized in clinical application.
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6 FUTURE DIRECTIONS
6.1 Removal of Background Contamination
In several sections of this thesis, background signals have been identified as important.
In the case of quantitation, background signals from phenol were used for normalization.
However, no other advantages to having such prominent background signals were
identified. Disadvantages include possible coelution with breath compounds and peak
tailing in the chromatogram leading to diminished resolution, higher noise levels as
characteristic masses are consistently found throughout the entire chromatogram, and
most notably background domination in numerical calculations.
Future efforts should be devoted to reducing background signals, and this study has
highlighted area to focus those efforts:
1) Phenol and Acetemide, N,N-dimethyl originate from Tedlar sampling bags. Heating
and purging with nitrogen gas was shown to reduce their presence. While the adsorption
temperature was chosen for physiological reasons, lower temperatures should be
investigate to determine if there is a balance between improvement in extraction
characteristics at higher temperatures and improvement in background contamination
levels at lower temperature. Complete reduction could also be achieved by exploring
other sampling options including alternative sampling vessels and direct to SPME
sampling.
2) The siloxane based contaminates observed actually originate from septa and polymer
coatings on SPME fibers and chromatographic columns. While it is difficult to reduce
signal contamination due to column bleed, fiber contamination can be limited by
exploring lower desorption temperatures. Care must be taken, to ensure that high flow in
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the inlet permits fast desorption times and burst delivery of compounds on to the column.
Lower desorption temperatures should also improve coating lifetime.
The GC inlet used in this study contained a prepunctured septum which limits
contamination. However, the septum fitting on tedlar bags represented a potentially
significant source of siloxane contamination. The needle tip of SPME holders can core
the septum when it is introduced into the collection bag. While large piece of septum do
not get into the SPME assembly, small particles can and may lead to contamination.
Future investigators that use Tedlar bags should investigate other septum materials.
6.2 Field Deployable Device
This work represented the initial phase of project to develop a standalone device for
disease detection. Before a field deployable device can be produce additional technical
considerations will need to be figured out. How will sampling and separation be done?
Recent work has demonstrated the feasibility of on-site SPME sampling, eliminating the
need for sample storage or transportation. Coupled with portable gas chromatography
and differential mobility spectrometers, this system has the potential to realize the
portability and convenience objectives that will make breath analysis clinically applicable.
Refinement to the method established in this thesis would be required to optimize
performance. Additionally, direct to fiber sampling with fast extraction times should be
explored for sample concentration. At fast extraction times and high sample flow rates,
analytes are efficiently adsorbed, minimizing competitive displacement, and improving
extraction precision.
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